Cost Comparison of Point-Of-Care and Conventional CD4 Testing in Resource-Limited Settings Ilesh V. Jani Instituto Nacional de Saúde Maputo, Mozambique.

Slides:



Advertisements
Similar presentations
Deputy Executive Director
Advertisements

UNDP RBA Workshop on MDG-Based National Development Strategies Module 4: Health Strategies UN Millennium Project February 27-March 3, 2006.
The Future of HIV Diagnostics: Market Trends for CD4 and VL Testing Decade of Diagnostics Satellite Kuala Lumpur July 2, 2013.
IT Implementation Cost The under appreciated costs of implementing a IT solution.
Business Planning for Health Organizations ID 536 April 25, 2008 Paul Campbell Harvard School of Public Health.
National Institute of Health of Mozambique (Instituto Nacional de Saúde, INS) Presentation to IANPHI General Assembly Ilesh V. Jani Director-General of.
Pilot Implementation of Point-Of-Care CD4 Counting in Mozambique’s National Health System Ilesh V. Jani Instituto Nacional de Saúde Maputo, Mozambique.
A Training Needs Analysis of Health Workforce Competencies in HIV Care and Treatment Services in Rwanda (L305) Presented by: Dr. Peter Memiah Presented.
The Current Pipeline for Point-of-Care Virologic Testing for HIV/AIDS Scaling up Virologic Diagnostic HIV Testing in Infants and Rationalizing Decentralization.
Evaluation of Point-Of-Care CD4 and Toxicity Monitoring for Resource-Limited ART Clinic Settings in Mozambique Ilesh V. Jani 1, Nádia Sitoe 1, Patrina.
Introducing New POC Devices in National Programs: Focus on Early Infant Diagnosis July 2014.
Bobby Jefferson Senior HMIS Advisor Futures Group The Site Capacity Assessment (SCA) Tool and other Mechanisms to Monitor Transition Status Track 1 Implementers.
WHO Guidelines for treatment monitoring Nathan Ford Dept of HIV/AIDS World Health Organization.
Stable Outcomes and Costs in South African Patients’ Second Year on Antiretroviral Treatment Lawrence Long, Health Economics Research Office, Wits Health.
Instrument and Test Forecasting: Considerations in Implementation of New Diagnostics Jason Williams Principal Laboratory Advisor.
MHRP  The views expressed are those of the authors and should not be construed to represent the positions of the U.S. Army or the Department of Defense.
Decentralization of HIV care and treatment services in Central Province, Kenya: Adult patient characteristics and outcomes Presenting author: William Reidy,
Possible solution: Change testing & care for patients in TB treatment Old system TB patient treated at TB center Referred to VCT center for HIV testing.
Cost Benefit Analysis of Computerization in Hospitals: A Marginal Cost Approach Dr. Haroon Khan Associate Professor Department of Pathology Pakistan Institute.
The UNITAID-funded MSF diagnostics project: Plans to incorporate the new WHO recommendations and how best practices will be shared with, and disseminated.
Antiretroviral Treatment Costs in Mexico WHO/UNAIDS Workshop on Strategic Information for Anti-Retroviral Therapy Programmes 30 June to 2 July, 2003 Assessment.
Accelerating access to innovative point of care HIV diagnostics Decade of Diagnostics Satellite Session Washington, DC July 22, 2012.
Evaluation of point of care CD4 Testing in Ethiopia Belete Tegbaru National HIV Laboratory The Ethiopian Health and Nutrition Research.
Ilesh V. Jani, MD PhD Instituto Nacional de Saúde Maputo, Mozambique.
The Rationale for Option B+ in Malawi
Group Discussion Guyana, The Bahamas T & T, Jamaica Barbados, Haiti Suriname, Curacao.
MDG Needs Assessment Training Workshop May 9-12, 2005 Health Module.
Agenda  Motivation and Overview (using Education as an example)  Discussion by Selected Intervention Area  Energy Services.
Charlie Masiku Deputy Medical Coordinator MSF HIV Project, Chiradzulu, Malawi Capetown 22nd September 2014 Early experience with implementation of SAMBA.
The HIV/AIDS Diagnostic Landscape: What does the Future Hold? Maurine M. Murtagh IAS 2011 Rome, Italy July 18, 2011.
Ministry of Health, Mozambique
Strengthening HR Capacity to Address the HIV Crisis Dr. Mphu Ramatlapeng Minister of Health, Lesotho 2 February 2012 Father Michael Kelly Lecture.
Decentralization of Laboratory Testing Capacity in Resource- Limited Settings: 7 Years of Experience in six African Countries F Marinucci,
Existing Challenges – POC Introduction Lab Technical Working Group Jason Williams, Principal Laboratory Advisor, SCMS January 20-21, 2013.
Is Highly Active Antiretroviral Therapy (HAART) in pregnancy protective against maternal mortality? Results from a large DREAM cohort in Malawi and Mozambique.
Ilesh V. Jani, MD PhD Instituto Nacional de Saúde Maputo, Mozambique.
The National HIV Counselling and Testing Campaign and Treatment Expansion in South Africa: A return on investments in combination prevention XIX International.
Data dissemination meeting February 28, 2007 ICAP New York.
Impact of Early Infant Diagnostic (EID) Testing for HIV Exposed Infants in Namibia Dr. Ndapewa Hamunime (MOHSS) Dr. Andreas Shiningavamwe (NIP) Republic.
Task-shifting in delivery of HIV care Partners In Health Perspective Louise Ivers MD, MPH Director, HIV Equity Initiative, Partners In Health, Haiti Harvard.
From HIV Testing to Treatment: Operations Research to Improve ARV Treatment Programs Treatment Acceleration Program Meeting November 30, 2006 Mark Micek,
INS Point-Of-Care CD4 Improves Patient Retention and Time-To-Initiation for ART in Mozambique Ilesh Jani 1, Nádia Sitoe 1, Eunice Alfai 1, Patrina Chongo.
Jeroen Van’t Pad Bosch, Technical Director Elizabeth Glaser Pediatric AIDS Foundation, Tanzania EGPAF PROJECT HEART STRENGTHENING HEALTH SYSTEMS THROUGH.
Evaluating a novel semi-quantitative viral load test in the field: field trial for patient monitoring in Malawi and Uganda Dr. Suna Balkan MSF.
Clinic systems should be adapted to maximize the benefits of point-of-care CD4 technology Point-of-Care CD4 Systems Integration in Uganda December 2011.
Presentation to the Health Portfolio Committee Presentation to Health Portfolio Committee Free State Department of Health 15 APRIL 2003.
Public-Private Partnership to Scale Up and Sustain TB and HIV Care in Ethiopia Tesfai Gabre-Kidan, MD Country Director, Private Health Sector Abt Associates.
Expert Patients and AIDS Ministry of HealthMSF-OCB Mozambique CDC From Field Operational Research to National Roll Out of CASG in Mozambique.
Boston University Slideshow Title Goes Here District Prevalence of Unsuppressed HIV in South African Women: Monitoring Programme Performance and Progress.
CDC and support for Point of Care Testing Accreditation Muthoni Junghae CDC-Kenya LAUNCH OFF POINT OF CARE TESTING ACCREDITATION PROGRAM PANAFRIC HOTEL-18TH.
Emphasis programmatic / civil society and lab must not act in silos – need to come together for effective scale up Programmatic and Laboratory Must Speak.
Patient and financial impact of implementing WHO recommendations for EID testing – expanding entry point testing and introduction of POC Jenna Mezhrahid.
Durban, July 20th 2016 Ruggero Giuliani MSF - Mozambique
Presented to the AIDS 2016 Conference
EVALUATING STABILIZATION TUBES FOR STORAGE OF CD4 HIV POSITIVE SAMPLES AT KILIFI DISTRICT HOSPITAL, KENYA Nella Raphael Kalama.
EID and Viral Load Product and Site Selection Tool
Using data to monitor POC performance
Facilitating development and adaptation of the right tools
Developing a Comprehensive Site Selection Process for a Cancer Network in a Resource-Limited Settings in Sub-Saharan Africa Meg Wirth AMC Operations &
Integrated Testing on the GeneXpert
3.2 Productivity Understand what is meant by productivity.
Madisa Mine National Health Laboratory Gaborone, BOTSWANA
Ilesh V. Jani Instituto Nacional de Saúde Mozambique
The Cost of Differentiated Service Delivery: A Systematic Review
Geomapping to Enhance Equitable Access
Effect of POC CD4 testing at HIV diagnosis on attrition prior to ART initiation among youth in Khayelitsha, South Africa Pre-treatment losses to care remains.
Cost/Benefit Analysis
Multi-disease diagnostic integration
Performance of mPima for quantification of HIV Viral load for pregnant and post-partum woman in primary health care clinics in Mozambique Team: B. Meggi.
Cost effective implementation of POC molecular testing and the impact on a priority population: EID and beyond.
Presentation transcript:

Cost Comparison of Point-Of-Care and Conventional CD4 Testing in Resource-Limited Settings Ilesh V. Jani Instituto Nacional de Saúde Maputo, Mozambique

Alere PIMA (Lab Techs) vs. BD FACSCalibur Alere PIMA (Nurses) vs. BD FACSCalibur Limits of Agreement -314 to +257 Limits of Agreement -249 to +148 Jani et al. (2011); AIDS Nurses in Primary Health Clinics Can Accurately Perform CD4 counts Using Point- Of-Care Devices

Percent Of Patients Receiving CD4 Test Results Percent Of Patients Returning After Initial CD4 Point-Of-Care CD4 Counting Reduces Pre- Treatment Loss-To-Follow-Up

Conventional CD4 (BD FACSCount) Higher throughput (50-75 tests/day) Large installed base (>1000 instruments across Africa) Takes advantage of existing infrastructure Performed by trained laboratory technicians May be more efficient and cheaper due to economies of scale Point-Of-Care CD4 (Alere Pima) Lower throughput (5-20 tests/day) New technology without large installed base Does not require significant infrastructure Performed by non- specialised personnel May be more expensive in certain settings Significant patient benefits Point-Of-Care Technologies Must Be Considered Against Conventional Laboratory- Based technologies

Methods Data were gathered from health facilities across 13 countries in sub-Saharan Africa: Reagent, control, and consumable costs Equipment and maintenance costs Lab infrastructure and overhead costs Sample transport costs Human resource salaries Site patient volumes Total cost per test for a site with known testing volume was calculated to determine if it would be less costly to refer samples to an existing CD4 laboratory or to implement Point-Of-Care CD4 testing on-site Cost is an Important Factor to Consider When Placing Point-Of-Care Devices

Conventional CD4 testing Costs Vary Significantly But Point-Of-Care CD4 Counting Costs Are Relatively Stable Across Countries Cost ComponentPrice Range Reagents$ $10.89 $5.95 plus distributor margin Other Consumables$ $1.61$1.00 Controls$ $0.52$100 per year Price per Instrument$27,000 (FACSCount)$5,000 (PIMA) Maintenance$4,000 per year$1,200 per year Freight10% of costs Lab Overhead$ $0.46$ $0.60 Sample Transport~$1.25 per sample 1 None Human Resources$ $2.10$ $1.15 Source: 1 Machinga District, Malawi

At Average Volumes of ~1,400 Tests/Yr Point- Of-Care CD4 Cost/Test is Comparable to Conventional CD4 Averages obscure higher reagent prices for laboratory based CD4 in some countries

CD4 Cost per Test CD4 Volume per Year per Site For a Single ART Site Referring Samples, Conventional CD4 Cost/Test Drops Slightly as Volumes Rise

CD4 Cost per Test CD4 Volume per Year per Site For a Single ART Site with Point-Of-Care CD4, Cost/Test Drops Dramatically as Volumes Rise Above 5,000 tests/year, a 2 nd device is required

CD4 Cost per Test CD4 Volume per Year per Site At 1,400 tests/yr per site (avg. CD4 demand at a health center in Africa), POC all-in costs are higher Cost is equal at ~2,900 tests per year at one site As Testing Volumes Rise, Point-Of-Care CD4 Testing Becomes More Cost-Competitive

CD4 Tests Demanded/Year Higher Volume Sites Comprise a Large Proportion of Point-Of-Care Test Demand Sites above >2,900 tests per year comprise >90% of CD4 test demand But it is more intuitive that POC would belong at small, remote sites!

Deploying Device Based Point-Of-Care CD4 at a (relatively) Modest Number of Higher Volume Sites Seems to Be Less Costly - But Site Selection Depends on Many Factors Other factors to consider: – Universal access – Equity – Distance to laboratories – Patient loss-to-follow-up – Size of catchment area – ART coverage – HIV prevalence – PMTCT services – Etc.

Kanimambo! Obrigado! Grazie! Thank You!